User profiles for Denise Battaglini
Denise BattagliniMD, PhD Verified email at hsanmartino.it Cited by 4584 |
[HTML][HTML] Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study
…, M Marchesi, C Robba, D Battaglini… - The Lancet …, 2021 - thelancet.com
Background To date, 750 000 patients with COVID-19 worldwide have required mechanical
ventilation and thus are at high risk of acute brain dysfunction (coma and delirium). We …
ventilation and thus are at high risk of acute brain dysfunction (coma and delirium). We …
Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis
…, NV Kannapadi, J Briggs, SM Seal, D Battaglini… - Journal of the …, 2022 - Elsevier
Importance Neurological and neuropsychiatric symptoms that persist or develop three
months after the onset of COVID-19 pose a significant threat to the global healthcare system. …
months after the onset of COVID-19 pose a significant threat to the global healthcare system. …
Bloodstream infections in critically ill patients with COVID‐19
DR Giacobbe, D Battaglini, L Ball… - European journal of …, 2020 - Wiley Online Library
Background Little is known about the incidence and risk of intensive care unit (ICU)‐acquired
bloodstream infections (BSI) in critically ill patients with coronavirus disease 2019 (COVID‐…
bloodstream infections (BSI) in critically ill patients with coronavirus disease 2019 (COVID‐…
[HTML][HTML] Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2
C Robba, D Battaglini, P Pelosi… - Expert review of …, 2020 - Taylor & Francis
In December 2019, an outbreak of viral pneumonia caused by a novel coronavirus (since
named SARS-CoV-2) was identified in Wuhan, China. Within few months, this disease–now …
named SARS-CoV-2) was identified in Wuhan, China. Within few months, this disease–now …
[HTML][HTML] Laboratory biomarkers for diagnosis and prognosis in COVID-19
D Battaglini, M Lopes-Pacheco… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) causes a wide spectrum
of clinical manifestations, with progression to multiorgan failure in the most severe cases. …
of clinical manifestations, with progression to multiorgan failure in the most severe cases. …
Distinct phenotypes require distinct respiratory management strategies in severe COVID-19
C Robba, D Battaglini, L Ball, M Loconte… - Respiratory physiology …, 2020 - Elsevier
Coronavirus disease 2019 (COVID-19) can cause severe respiratory failure requiring
mechanical ventilation. The abnormalities observed on chest computed tomography (CT) and the …
mechanical ventilation. The abnormalities observed on chest computed tomography (CT) and the …
[HTML][HTML] Pathogenesis of multiple organ injury in COVID-19 and potential therapeutic strategies
…, PL Silva, FF Cruz, D Battaglini… - Frontiers in …, 2021 - frontiersin.org
Severe acute respiratory disease coronavirus 2 (SARS-CoV-2, formerly 2019-nCoV) is a
novel coronavirus that has rapidly disseminated worldwide, causing the coronavirus disease …
novel coronavirus that has rapidly disseminated worldwide, causing the coronavirus disease …
[HTML][HTML] Incidence and prognosis of ventilator-associated pneumonia in critically ill patients with COVID-19: a multicenter study
DR Giacobbe, D Battaglini, EM Enrile… - Journal of clinical …, 2021 - mdpi.com
The primary objective of this multicenter, observational, retrospective study was to assess
the incidence rate of ventilator-associated pneumonia (VAP) in coronavirus disease 2019 (…
the incidence rate of ventilator-associated pneumonia (VAP) in coronavirus disease 2019 (…
Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19
D Battaglini, C Robba, S Caiffa, L Ball, I Brunetti… - Respiratory physiology …, 2020 - Elsevier
In late 2019, an outbreak of a novel human coronavirus causing respiratory disease was
identified in Wuhan, China. The virus spread rapidly worldwide, reaching pandemic status. …
identified in Wuhan, China. The virus spread rapidly worldwide, reaching pandemic status. …
[HTML][HTML] Pros and cons of corticosteroid therapy for COVID-19 patients
…, NS Felix, PL Silva, C Robba, D Battaglini… - Respiratory physiology …, 2020 - Elsevier
In December 2019, an outbreak of severe pneumonia was reported in Wuhan, China. Later
described as COVID-19 (coronavirus disease 2019), this infection caused by a virus from the …
described as COVID-19 (coronavirus disease 2019), this infection caused by a virus from the …